271 related articles for article (PubMed ID: 20692538)
1. Pulmonary manifestations of scleroderma and mixed connective tissue disease.
Hant FN; Herpel LB; Silver RM
Clin Chest Med; 2010 Sep; 31(3):433-49. PubMed ID: 20692538
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary manifestations of systemic lupus erythematosus.
Memet B; Ginzler EM
Semin Respir Crit Care Med; 2007 Aug; 28(4):441-50. PubMed ID: 17764061
[TBL] [Abstract][Full Text] [Related]
3. Association of psoriasin (S100A7) with clinical manifestations of systemic sclerosis: is its presence in whole saliva a potential predictor of pulmonary involvement?
Baldini C; Giusti L; Bazzichi L; Ciregia F; Giannaccini G; Giacomelli C; Doveri M; Del Rosso M; Bombardieri S; Lucacchini A
J Rheumatol; 2008 Sep; 35(9):1820-4. PubMed ID: 18634149
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary vascular manifestations of mixed connective tissue disease.
Bull TM; Fagan KA; Badesch DB
Rheum Dis Clin North Am; 2005 Aug; 31(3):451-64, vi. PubMed ID: 16084318
[TBL] [Abstract][Full Text] [Related]
5. [Lung impairment in systemic sclerosis].
Knoop H; Arinir U; Kreuter A; Walther JW; Schultze-Werninghaus G; Rohde G
Pneumologie; 2009 Sep; 63(9):497-507. PubMed ID: 19708006
[TBL] [Abstract][Full Text] [Related]
6. The prognosis of mixed connective tissue disease.
Lundberg IE
Rheum Dis Clin North Am; 2005 Aug; 31(3):535-47, vii-viii. PubMed ID: 16084324
[TBL] [Abstract][Full Text] [Related]
7. South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome.
Graf SW; Hakendorf P; Lester S; Patterson K; Walker JG; Smith MD; Ahern MJ; Roberts-Thomson PJ
Int J Rheum Dis; 2012 Feb; 15(1):102-9. PubMed ID: 22324953
[TBL] [Abstract][Full Text] [Related]
8. Lung involvement in systemic sclerosis.
Silver RM; Miller KS
Rheum Dis Clin North Am; 1990 Feb; 16(1):199-216. PubMed ID: 2406808
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database.
Carreira PE; Carmona L; Joven BE; Loza E; Andreu JL; Riemekasten G; Vettori S; Balbir-Gurman A; Airò P; Walker UA; Damjanov N; Matucci-Cerinic M; Ananieva LP; Rednic S; Czirják L; Distler O; Farge D; Hesselstrand R; Corrado A; Caramaschi P; Tikly M; Allanore Y;
Clin Exp Rheumatol; 2018; 36 Suppl 113(4):68-75. PubMed ID: 30277860
[TBL] [Abstract][Full Text] [Related]
10. Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis.
Kodera M; Hasegawa M; Komura K; Yanaba K; Takehara K; Sato S
Arthritis Rheum; 2005 Sep; 52(9):2889-96. PubMed ID: 16142750
[TBL] [Abstract][Full Text] [Related]
11. MCTD: is it rare in India?
Lawrence A; Aggarwal A; Misra R
Clin Rheumatol; 2007 Feb; 26(2):205-7. PubMed ID: 16598411
[TBL] [Abstract][Full Text] [Related]
12. Treatment of mixed connective tissue disease.
Kim P; Grossman JM
Rheum Dis Clin North Am; 2005 Aug; 31(3):549-65, viii. PubMed ID: 16084325
[TBL] [Abstract][Full Text] [Related]
13. The importance of recognizing scleroderma-type disorders in clinical practice.
Hummers LK
Nat Clin Pract Rheumatol; 2008 Dec; 4(12):638-40. PubMed ID: 18957945
[No Abstract] [Full Text] [Related]
14. [Contemporaneous clinical picture of systemic sclerosis].
Wiesik-Szewczyk E; Olesińska M
Pol Merkur Lekarski; 2010 May; 28(167):416-20. PubMed ID: 20568410
[TBL] [Abstract][Full Text] [Related]
15. [An up date on pulmonary hypertension related to systemic sclerosis].
Kowal-Bielecka O; Sulik A; Sierakowski S
Przegl Lek; 2005; 62(8):813-7. PubMed ID: 16521504
[TBL] [Abstract][Full Text] [Related]
16. Lungs in mixed connective tissue disease.
Prakash UB
J Thorac Imaging; 1992 Mar; 7(2):55-61. PubMed ID: 1578526
[TBL] [Abstract][Full Text] [Related]
17. Time to diagnosis in systemic sclerosis: is sex a factor?
Hudson M; Thombs B; Baron M;
Arthritis Rheum; 2009 Feb; 61(2):274-8. PubMed ID: 19177534
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
Launay D; Mouthon L; Hachulla E; Pagnoux C; de Groote P; Remy-Jardin M; Matran R; Lambert M; Queyrel V; Morell-Dubois S; Guillevin L; Hatron PY
J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary manifestations of Sjögren syndrome, systemic lupus erythematosus, and mixed connective tissue disease.
Mira-Avendano IC; Abril A
Rheum Dis Clin North Am; 2015 May; 41(2):263-77. PubMed ID: 25836642
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study of interstitial lung disease in mixed connective tissue disease].
Colin G; Nunes H; Hatron PY; Cadranel J; Tillie I; Wallaert B
Rev Mal Respir; 2010 Mar; 27(3):238-46. PubMed ID: 20359616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
